SI9400061A - Derivatives of amino-ascorbic acid, the processes for their preparation and use - Google Patents

Derivatives of amino-ascorbic acid, the processes for their preparation and use Download PDF

Info

Publication number
SI9400061A
SI9400061A SI9400061A SI9400061A SI9400061A SI 9400061 A SI9400061 A SI 9400061A SI 9400061 A SI9400061 A SI 9400061A SI 9400061 A SI9400061 A SI 9400061A SI 9400061 A SI9400061 A SI 9400061A
Authority
SI
Slovenia
Prior art keywords
ascorbic acid
amino
benzyl
general formula
formula
Prior art date
Application number
SI9400061A
Other languages
English (en)
Slovenian (sl)
Inventor
Bozidar Suskovic
Vanja Vela
Mira Buncic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of SI9400061A publication Critical patent/SI9400061A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
SI9400061A 1993-02-05 1994-02-04 Derivatives of amino-ascorbic acid, the processes for their preparation and use SI9400061A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR930131A HRP930131A2 (en) 1993-02-05 1993-02-05 Amino-ascorbic acid derivatives, process for the preparation and use thereof
JP6013667A JPH07101950A (ja) 1993-02-05 1994-02-07 アミノ−アスコルビン酸誘導体、その製造法及び用途

Publications (1)

Publication Number Publication Date
SI9400061A true SI9400061A (en) 1994-09-30

Family

ID=26316867

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9400061A SI9400061A (en) 1993-02-05 1994-02-04 Derivatives of amino-ascorbic acid, the processes for their preparation and use

Country Status (11)

Country Link
EP (3) EP0791587A1 (cs)
JP (1) JPH07101950A (cs)
CN (1) CN1099753A (cs)
BG (1) BG62167B1 (cs)
CA (1) CA2114970C (cs)
CZ (1) CZ24594A3 (cs)
HR (1) HRP930131A2 (cs)
HU (1) HUT71606A (cs)
PL (1) PL302144A1 (cs)
SI (1) SI9400061A (cs)
SK (1) SK12894A3 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4980911B2 (ja) 2005-01-25 2012-07-18 パナソニック株式会社 電源システム
KR101119027B1 (ko) * 2009-05-07 2012-03-14 (주)코스몰 아스코르빈산 유도체의 제조방법
JP2013230984A (ja) * 2010-08-19 2013-11-14 Seiwa Kasei Co Ltd アスコルビン酸由来組成物、その製造方法、及び化粧料
CN108368202B (zh) * 2015-12-03 2020-10-16 3M创新有限公司 具有光不稳定还原剂的氧化还原可聚合组合物
CN115260170B (zh) * 2021-04-30 2024-05-28 禾美生物科技(浙江)有限公司 抗坏血酸多肽衍生物及其制备方法和应用
CN114369075B (zh) * 2022-02-14 2023-09-29 河北乐开节能科技股份有限公司 利用2-酮基-l-古龙酸的水溶液一步制备vc结晶的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2616351A1 (de) * 1975-05-03 1976-11-11 Hoffmann La Roche Halogenderivate
US4504462A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
EP0446539A1 (en) * 1990-03-16 1991-09-18 Merrell Dow Pharmaceuticals Inc. Novel ascorbic acid derivatives

Also Published As

Publication number Publication date
JPH07101950A (ja) 1995-04-18
PL302144A1 (en) 1994-08-08
EP0791587A1 (en) 1997-08-27
SK12894A3 (en) 1994-12-07
BG98438A (bg) 1994-09-30
CZ24594A3 (en) 1994-08-17
BG62167B1 (bg) 1999-04-30
HU9400325D0 (en) 1994-05-30
EP0791588A1 (en) 1997-08-27
CA2114970C (en) 1999-06-22
EP0609899A1 (en) 1994-08-10
HUT71606A (en) 1996-01-29
HRP930131A2 (en) 1997-02-28
CA2114970A1 (en) 1994-08-06
CN1099753A (zh) 1995-03-08

Similar Documents

Publication Publication Date Title
Nishizawa et al. Synthesis and structure-activity relations of bestatin analogs, inhibitors of aminopeptidase B
AU715049B2 (en) N-substituted piperazine nonoates
EP0227355A2 (en) Prodrugs of rapamycin
Lin et al. Potential bioreductive alkylating agents. 4. Inhibition of coenzyme Q enzyme systems by lipoidal benzoquinone and naphthoquinone derivatives
SI9400061A (en) Derivatives of amino-ascorbic acid, the processes for their preparation and use
Iyengar et al. Preparation and antitumor activity of 7-substituted 1, 2-aziridinomitosenes
FI111247B (fi) Uusi b-fenyyli-isoseriinijohdannainen, sen valmistus ja käyttö
Wagenaar et al. Methodology for the preparation of N-guanidino-modified arginines and related derivatives
AU722595B2 (en) Urethane mediated, GST specific molecular release systems
Fikes et al. Preassociating. alpha.-nucleophiles
Muszalska Studies of the degradation mechanism of pyrrolo [3, 4-c] pyridine-1, 3 (2H)-dione derivatives with analgesic activity: isolation and identification of products and summary
Fowler 2-Methyl-3-butyn-2-ol as an acetylene precursor in the Mannich reaction. A new synthesis of suicide inactivators of monoamine oxidase
Zhou et al. Synthesis and photochemical studies of 2-nitrobenzyl-caged N-hydroxysulfonamides
US5559251A (en) Derivatives of amino-ascorbic acid, the processes for their preparation and use
EP4100411B1 (en) Compounds constituting c20-modified salinomycin derivatives, a method for obtaining the same, a composition containing the same, a use of said compounds and a method for obtaining an intermediate product
Bruice et al. Aminolysis of substituted phenyl quinoline-8-and-6-carboxylates with primary and secondary amines. Involvement of proton-slide catalysis
DK161833B (da) Analogifremgangsmaade til fremstilling af n-(vinblastinoyl-23)-derivater af aminosyrer eller farmaceutisk acceptable syreadditionssalte deraf
RU2126398C1 (ru) Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты
Chen et al. Photoinduced regioselective difluorination of secondary inert C (sp 3)–H bonds in sulfonamides via 1, 5-hydrogen-atom transfer
KLEHR et al. Formation of 4-Ethoxy-4’-nitrosodiphenylamine in the Reaction of the Phenacetin Metabolite 4-Nitrosophenetol with Glutathione
NISHIZAWA et al. Synthesis and biological activity of spergualin analogues. I.
Highfield et al. Preparative, physico-chemical and cytotoxicity studies of prodrugs activated in hypoxia to give metal-binding analogues of bleomycin
US6015811A (en) Antitumor Chrysene derivatives
Kumar et al. Caffeine-derived N-nitroso compounds. II. Synthesis and characterization of nitrosation products from caffeidine and caffeidine acid
Thanassi Reaction of diaminomaleonitrile with acetaldehyde